Newsletter Tool

To view this email as a web page, click here

Today's Rundown

Could a breast cancer candidate treat COVID-19? Polyphor's drug shows dual action in early studies
UPDATED Coronavirus tracker: Adolescent hospitalizations for COVID tick up in March, April, CDC says
HHS: ACA exchange, Medicaid expansion coverage reaches record 31M
Fueled by COVID drug manufacturing revenues, CDMO Jubilant HollisterStier invests in upgrades, expansion
COVID-19 tracker: Obesity is the top risk factor for severe COVID, study says; Translate to get $50M milestone payment from Sanofi
Merck investigating noose at NC vaccine plant as execs pledge swift response

Featured Story

Could a breast cancer candidate treat COVID-19? Polyphor's drug shows dual action in early studies

By Angus Liu

A Swiss biotech suggests that one of its clinical candidates, currently in late-stage development for breast cancer, may also work as a COVID-19 treatment. The drug, called balixafortide, reduced viral load of the coronavirus that causes COVID, as well as COVID-related inflammation markers, in hamsters.

UPDATED Coronavirus tracker: Adolescent hospitalizations for COVID tick up in March, April, CDC says

By Healthcare Staff

Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.

HHS: ACA exchange, Medicaid expansion coverage reaches record 31M

By Robert King

A record 31 million people have received coverage through the ACA's insurance exchanges and Medicaid expansion, according to a new report from HHS.

Fueled by COVID drug manufacturing revenues, CDMO Jubilant HollisterStier invests in upgrades, expansion

By Kevin Dunleavy

Jubilant HollisterStier has been busy churning out COVID-19 treatments and is now turning those revenues from the increased business into an investment in the future. This week the Washington-based CDMO revealed a $92 million expansion plan.

COVID-19 tracker: Obesity is the top risk factor for severe COVID, study says; Translate to get $50M milestone payment from Sanofi

By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner

A study shows that obesity is the highest risk factor predicting severe COVID-19 in those under 40. Translate Bio will receive $50M in milestone payments from Sanofi for mRNA vaccine development. And more headlines.

Merck investigating noose at NC vaccine plant as execs pledge swift response